BHC
Bausch Health Cos Inc
NYSE · Pharmaceuticals
$5.88
+0.15 (+2.62%)
Performance
1D
—
1W
+2.08%
1M
-21.50%
3M
-13.66%
6M
-17.99%
1Y
-6.96%
YTD
-18.45%
Open$5.78
Previous Close$5.73
Day High$5.90
Day Low$5.77
52W High$11.97
52W Low$5.91
Volume1.36M
Avg Volume570.5K
Market Cap2.90B
P/E Ratio5.87
EPS$0.97
SectorPharmaceuticals
Volume Analysis
2.39x average volume
Technical Indicators
SMA 50
$6.76
Below
SMA 200
$6.33
Below
RSI (14)
20.7
Oversold
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Sell
9 analysts
Price Target
+1,665.0% upside
Current
$5.88
$5.88
Target
$103.78
$103.78
$65.08
$103.78 avg
$115.24
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 12.92B | 12.36B | 465.96M |
| Net Income | -61,752,823 | -53,184,249 | 102.50M |
| Profit Margin | -0.5% | -0.5% | 22.0% |
| EBITDA | 3.55B | 3.23B | 190.54M |
| Free Cash Flow | — | — | 97.27M |
| Rev Growth | +4.5% | +4.5% | +23.7% |
| Debt/Equity | 44.72 | 44.72 | 0.38 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |